INNATE PHARMA SA (IPH.PA) Stock Price, Quote, News and Overview

What is the stock price of INNATE PHARMA SA today?

The current stock price of IPH.PA is 2.045 EUR. The price decreased by -1.45% in the last trading session.

What is the ticker symbol for INNATE PHARMA SA stock?

The exchange symbol of INNATE PHARMA SA is IPH and it is listed on the Euronext Paris - Matif exchange.

On which exchange is IPH.PA stock listed?

IPH.PA stock is listed on the Euronext Paris - Matif exchange.

What is the price forecast or stock price prediction for INNATE PHARMA SA stock?

11 analysts have analysed IPH.PA and the average price target is 5.27 EUR. This implies a price increase of 157.67% is expected in the next year compared to the current price of 2.045. Check the INNATE PHARMA SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is INNATE PHARMA SA worth?

INNATE PHARMA SA (IPH.PA) has a market capitalization of 188.46M EUR. This makes IPH.PA a Micro Cap stock.

How many employees does INNATE PHARMA SA have?

INNATE PHARMA SA (IPH.PA) currently has 181 employees.

What are the support and resistance levels for INNATE PHARMA SA (IPH.PA) stock?

INNATE PHARMA SA (IPH.PA) has a support level at 1.93 and a resistance level at 2.07. Check the full technical report for a detailed analysis of IPH.PA support and resistance levels.

Is INNATE PHARMA SA (IPH.PA) expected to grow?

The Revenue of INNATE PHARMA SA (IPH.PA) is expected to grow by 86.96% in the next year. Check the estimates tab for more information on the IPH.PA EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy INNATE PHARMA SA (IPH.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of IPH.PA, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of IPH.PA, evaluating the profitability, health, valuation and growth aspects
• INNATE PHARMA SA (IPH.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• INNATE PHARMA SA (IPH.PA) Sales and EPS estimates to see what analysts future expectations are.
• INNATE PHARMA SA (IPH.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• INNATE PHARMA SA (IPH.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
• INNATE PHARMA SA (IPH.PA) Stock Chart to make your own analysis
• INNATE PHARMA SA (IPH.PA) Latest news and press-releases to stay up to date.

Does INNATE PHARMA SA (IPH.PA) stock pay dividends?

IPH.PA does not pay a dividend.

When does INNATE PHARMA SA (IPH.PA) report earnings?

INNATE PHARMA SA (IPH.PA) will report earnings on 2025-05-13.

What is the Price/Earnings (PE) ratio of INNATE PHARMA SA (IPH.PA)?

INNATE PHARMA SA (IPH.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.61).

ChartMill assigns a fundamental rating of 2 / 10 to IPH.PA. IPH.PA may be in some trouble as it scores bad on both profitability and health.

Over the last trailing twelve months IPH.PA reported a non-GAAP Earnings per Share(EPS) of -0.61. The EPS decreased by -549.63% compared to the year before.

ChartMill assigns a Buy % Consensus number of 78% to IPH.PA. The Buy consensus is the average rating of analysts ratings from 11 analysts.

For the next year, analysts expect an EPS growth of 121.73% and a revenue growth 86.96% for IPH.PA